Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma (NHL) is a diverse group of hematologic malignancies originating from lymphocytes (B-cells, T-cells, or NK cells). Unlike Hodgkin Lymphoma, NHL lacks Reed-Sternberg cells and exhibits highly variable clinical behavior, ranging from indolent (slow-growing) to aggressive (rapidly progressing) forms.

The exact cause remains largely unknown, but it arises from somatic mutations in lymphoid cells. Genetic instability, translocation (e.g., t(14;18)), and epigenetic alterations drive malignant transformation. Lifestyle factors include obesity and chemical exposure, while genetic predisposition remains minor compared to acquired somatic mutations.

NHL involves the uncontrolled clonal proliferation of malignant lymphocytes within the lymphatic system. Proliferation typically occurs in lymph nodes, spleen, or extranodal sites (GI tract, CNS). Aggressive forms result from mutations disrupting cell cycle regulation (MYC/BCL2), while indolent forms often involve inhibited apoptosis.

NHL accounts for approximately 4% of all cancers. Incidence increases with age, peaking in the 6th–7th decade. It is slightly more prevalent in males and Caucasian populations.

• Immunosuppression (HIV/AIDS, organ transplant)
• Autoimmune diseases (Sjogren’s, RA)
• Infectious agents (EBV, H. pylori, Hepatitis C, HTLV-1)
• Exposure to ionizing radiation or herbicides (glyphosate)
• Advanced age

A. Early Symptoms

• Painless lymphadenopathy


• Unexplained fatigue


• Low-grade fever B. Common Symptoms


• "B-symptoms" (night sweats, weight loss >10%, fever)


• Generalized pruritus


• Abdominal distention or fullness C. Advanced Symptoms


• Bone pain


• Neurological deficits (if CNS involvement)


• Significant hepatosplenomegaly D. Emergency Symptoms


• Superior Vena Cava (SVC) syndrome


• Spinal cord compression


• Bowel obstruction or perforation

Palpation reveals firm, non-tender, rubbery lymphadenopathy (cervical, axillary, inguinal). Auscultation may reveal diminished breath sounds (pleural effusion). Abdominal exam often shows hepatosplenomegaly or palpable masses.

A. Clinical Assessment: Comprehensive history and nodal mapping.
B. Laboratory Testing: CBC, LDH, uric acid, viral screens (HBV, HCV, HIV).
C. Imaging Studies: PET-CT for staging.
D. Functional Tests: Cardiac MUGA scan (pre-anthracycline).
E. Biopsy Findings: Excisional lymph node biopsy (gold standard) for histopathology and flow cytometry.
F. Genetic Testing: FISH or PCR for chromosomal translocations.
G. Differential Diagnosis: Hodgkin lymphoma, tuberculosis, mononucleosis, sarcoidosis.

Lactate Dehydrogenase (LDH)
Type: Blood Test
Purpose: Assess tumor burden and cell turnover.
Expected Findings: Elevated levels.
Interpretation: Correlates with aggressive histology and poorer prognosis.

PET-CT (Fluorodeoxyglucose): Critical for baseline staging and assessing metabolic response to chemotherapy.

Hodgkin Lymphoma (differentiated by biopsy findings of Reed-Sternberg cells), Reactive Lymphadenopathy, Metastatic Carcinoma.

• Tumor Lysis Syndrome (TLS)
• Treatment-related cardiotoxicity
• Secondary malignancies
• Infectious complications (neutropenia)

A. Lifestyle Modifications: Smoking cessation, nutritional support.
B. Preventive Measures: Vaccination (in consultation with oncology).
C. Medical Treatment:

• Immunotherapy: Rituximab (anti-CD20).


• Chemotherapy: CHOP regimen (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone).


• Targeted Therapy: BTK inhibitors (Ibrutinib).

Highly variable. Indolent lymphomas are often incurable but manageable for decades. Aggressive lymphomas are potentially curable with intensive chemo-immunotherapy.

No definitive primary prevention; secondary prevention involves managing underlying infections (e.g., H. pylori eradication).

The following homeopathic remedies have been historically indicated for symptoms associated with Non-Hodgkin Lymphoma. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Non-Hodgkin Lymphoma.